Cytostatic activity of antiviral acyclic nucleoside phosphonates in rodent lymphocytes


    loading  Checking for direct PDF access through Ovid

Abstract

Acyclic nucleoside phosphonates (ANPs) inhibit replication of both DNA viruses and retroviruses, including HIV. The major mechanism of their antiviral action is inhibition of virus-induced DNA polymerases and/or of reverse transcriptases. We investigated the effects of ANPs on proliferation of mitogen-stimulated mouse and rat splenocytes. Included in the study were compounds differing at the heterocyclic base, i.e., adenine (A) and 2,6-diaminopurine (DAP), and at the N9-side chain, i.e., 9-[2-(phosphonomethoxy)ethyl] (PME) and (R)- or (S)-enantiomers of 9-[2-(phosphonomethoxy)propyl] (PMP) moieties, and their numerous N6-substituted derivatives. The medial inhibitory concentrations (IC50) of N6-nonsubstituted compounds range from 0.13 (PMEDAP) to 354 μM ((R)-PMPA). Antiproliferative effects are more pronounced in PME than in PMP series, and they are more prominent in DAP compared to A analogs. The (S)-enantiomers of PMP series are more effective than corresponding (R)-congers. The highest cytostatic potential is exhibited by N6-allyl-PMEDAP (IC50 = 0.017 μM) and N6-cyclopropyl-PMEDAP (IC50 = 0.036 μM). The N6-substituted derivatives of (S)-PMPA are virtually devoid of cytostatic activity. No tight correlation between the cytostatic and reported antiviral effects could be detected.

    loading  Loading Related Articles